Journal of the Neurological Sciences
Volume 223, Issue 2 , Pages 203-204 , 30 August 2004

Letter to the Editor

Received 23 February 2004

References 

  1. Chen C, Biller J, Willing SJ, Lopez AM. Ischemic stroke after using over the counter products containing ephedra. J. Neurol. Sci. 2004;217:55–60
  2. Chu CT, Gray L, Goldstein LB, Hulette CM. Diagnosis of intracranial vasculitis: a multidisciplinary approach. J. Neuropathol. Exp. Neurol. 1998;57:30–38
  3. Alrawi A, Trobe JD, Blaivas M, Musch DC. Brain biopsy in primary angiitis of the central nervous system. Neurology. 1999;53:858–860
  4. Calabrese LH, Duna GF, Lie JT. Vasculitis in the central nervous system. Arthritis Rheum. 1997;40:1189–1201
  5. Calabrese LH, Gragg LA, Furlan AJ. Benign angiopathy: a distinct subset of angiographically defined primary angitis of the central nervous system. J. Rheumatol. 1993;20:2046–2050
  6. Konrad C, Nabavi DG, Junker R, Dziewas R, Henningsen H, Stogbauer F. Spontaneous internal carotid artery dissection and alpha-1-antitrypsin deficiency. Acta Neurol. Scand. 2003;107:233–236
  7. Pezzini A, Zotto ED, Archetti S, Negrini R, Bani P, Albertini A, et al.  Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke. 2002;33:664–669
  8. Morgenstern LB, Viscoli CM, Kernan WN, Brass LM, Broderick JP, Feldman E, et al.  Use of ephedra-containing products and risk for hemorrhagic stroke. Neurology. 2003;60:132–135
  9. Kernan WN, Brass LM, Viscoli CM, Broderick JP, Brott T, Feldman E, et al.  Use of ephedra-containing products and risk for hemorrhagic stroke. Neurology. 2003;61:724–725
  10. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance. JAMA. 2003;289:1537–1545

PII: S0022-510X(04)00099-1

doi: 10.1016/j.jns.2004.03.030

Journal of the Neurological Sciences
Volume 223, Issue 2 , Pages 203-204 , 30 August 2004